İbrahim E. Pınar and V. Ozkocaman, “Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma”, Eur Res J, vol. 9, no. 6, pp. 1483–1492, Nov. 2023, doi: 10.18621/eurj.1359362.